Status:
COMPLETED
Intergenerational Behavioral Intervention to Enhance Physical Activity in Older Adults at Risk for Alzheimer's Disease
Lead Sponsor:
Douglas Mental Health University Institute
Collaborating Sponsors:
Montreal Neurological Institute and Hospital
McGill University
Conditions:
Physical Inactivity
Eligibility:
All Genders
60-95 years
Phase:
NA
Brief Summary
This is a four-week pilot randomized controlled trial of a behavioral intervention in older adults at risk for Alzheimer's disease. Older participants are a subgroup from the PREVENT-AD longitudinal c...
Detailed Description
This study is a two-arm, single-site randomized controlled trial to test whether a four-week technology-based intergenerational social motivation intervention enhances physical activity in 60 cognitiv...
Eligibility Criteria
Inclusion
- Main Participant Inclusion criteria:
- Men and women \> 60 years Who are current participants of the PREVENT-AD Longitudinal Cohort at McGill University.
- No contraindications to MRI Imaging. Normal cognition Not exercising more than 150 minutes of moderate-intensity exercise per week or sitting more than 8 hours per day AND responded "yes" to the question "Do you want to increase your physical activity?" Fluency in English or French Access to a computer or smartphone with internet Normal or corrected-to-normal vision based on the minimal 20/20 standard Ambulatory without significant increase in pain with walking or the assistance of walking devices
- Main Participant
Exclusion
- Primary care physician does not approve additional physical activity An inability to ambulate without the assistance of another person or severe pain
- Any unstable medical condition:
- History of a psychiatric illness including schizophrenia or Attention Deficit Hyperactivity Disorder (ADHD). History of anxiety or depression accepted if stable on medication for at least 6 months
- Current treatment for cancer - except non-melanoma skin cancer
- Neurological condition (e.g., multiple sclerosis, Parkinson's disease, and stroke)
- Current alcohol or substance abuse
- Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, Deep Venous Thrombosis (DVT) or other unstable cardiovascular condition
- Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac event in the past six months.
- Younger Adult Inclusion Criteria:
- Can be identified as child or grandchild of participant (biological or adopted), 14 years or older.
- Can be a young adult (18 years or older) who is not a relative of the main participant, in case a grandchild or child is not available.
- Stable on antidepressants for more than 6 months.
- In contact with the primary participant more than once per 12 months at baseline
- Lives anywhere in Canada if 18 years and older, or anywhere accessible by mail in Quebec if 14 years and older but younger than 18 years.
- Normal or corrected-to-normal vision based on the minimal 20/20 standard to complete the cognitive tasks
- Able to speak, read, and write English or French
- No diagnosis of neurological disease or unstable health condition
- Study Partner
Key Trial Info
Start Date :
October 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06038643
Start Date
October 8 2023
End Date
May 30 2024
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Montreal, Quebec, Canada, H4H 1R3